ReviewFrontiers in oncology2022

Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups.

Chinyereugo M Umemneku-Chikere et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.